In trading on Tuesday, shares of Novavax, Inc. (Symbol: NVAX) entered into oversold territory, hitting an RSI reading of 28.8, after changing hands as low as $7.89 per share. By comparison ...

Deep-pocketed investors have adopted a bullish approach towards Novavax (NASDAQ:NVAX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...

Shares of Novavax (NVAX), a pharmaceutical company, declined over 6% following the release of its third-quarter results. Though the company reported a lower-than-expected loss and surpassed ...

Novavax, Inc. ( NASDAQ:NVAX ) investors will be delighted, with the company turning in some strong numbers with ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Novavax, Inc. (Symbol: NVAX), where a total of 61,950 contracts have traded so far ...

(RTTNews) - Novavax Inc. (NVAX) released Loss for third quarter that decreased from last year and beat the Street estimates. The company's bottom line totaled -$121.30 million, or -$0.76 per share.

Novavax (NVAX) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.87. This compares to loss of $1.26 per share a year ago. These figures are ...

Novavax NVAX incurred a third-quarter 2024 loss of 76 cents per share, narrower than the Zacks Consensus Estimate of a loss of 87 cents. In the year-ago quarter, the company reported a loss of $1. ...

BofA lowered the firm’s price target on Novavax (NVAX) to $12 from $14 and keeps a Neutral rating on the shares. The company announced Nuvaxovid sales of $38.2M, which beat consensus ...

TD Cowen lowered the firm’s price target on Novavax (NVAX) to $9 from $14 and keeps a Hold rating on the shares. The firm said the FDA lifted its clinical hold on its COVID/flu combo and ...

Novavax NVAX was in focus this week as investors were ... achieving sustained target inhibition for three months. The Nasdaq Biotechnology Index has lost 1.94% in the past five trading sessions ...

Novavax Inc (NVAX) reports increased product sales and a strong cash position, while revising revenue guidance and navigating ...